Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.32%
1,100.57
-3.53
-0.32%
—1,104.101,103.921,108.751,097.16——
SIXC
Communications
SIXC
Communications
SIXC
+0.16%
605.15
+0.99
+0.16%
—604.16604.16610.19604.12——
SIXE
Energy
SIXE
Energy
SIXE
-0.22%
1,195.19
-2.62
-0.22%
—1,197.811,200.581,213.071,192.02——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.03%
1,739.91
-0.50
-0.03%
—1,740.411,739.551,750.271,730.60——
SIXM
Financials
SIXM
Financials
SIXM
+0.65%
638.56
+4.12
+0.65%
—634.44633.13639.87633.01——
SIXR
Staples
SIXR
Staples
SIXR
-1.11%
831.57
-9.33
-1.11%
—840.90839.53841.73831.10——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
213.36
-1.77
-0.82%
—215.13215.13215.85213.24——
SIXT
Technology
SIXT
Technology
SIXT
+0.17%
3,234.18
+5.47
+0.17%
—3,228.713,225.623,235.433,198.95——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.02%
935.65
-0.22
-0.02%
—935.87938.37942.00935.65——
SIXV
Health care
SIXV
Health care
SIXV
-0.54%
1,449.26
-7.86
-0.54%
—1,457.121,452.741,466.881,449.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,382.45
-17.39
-0.72%
—2,399.842,389.712,394.612,371.22——
CORT:NASDAQ
Corcept Therapeutics Inc
$46.22
+0.35%
(+0.16) 1D
$46.22
0.00% (0.00)
After hours
Closed: Apr 27, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CORT...
Open
$46.22
High
$47.00
Low
$45.70
Mkt. cap
4.96B
Avg. vol.
1.70M
Volume
646.70K
P/E ratio
55.65
52-wk high
$91.00
52-wk low
$28.66
EPS
$0.83
Beta
0.25
Shares outstanding
107.36M
No. of employees
730
News stories
From sources across the web
Profile
Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD. Wikipedia
About Corcept Therapeutics Inc
CEO-
Employees730
FoundedMay 13, 1998
HeadquartersMenlo Park, California, United States
SectorPharmaceutical industry
Website-
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
157.21M
194.43M
207.64M
202.12M
Cost of goods sold
2.40M
3.43M
4.60M
2.54M
Cost of revenue
2.40M
3.43M
4.60M
2.54M
Research and development expenses
60.74M
60.47M
68.85M
64.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
90.66M
103.85M
123.98M
130.24M
Operating expense
151.40M
164.32M
192.82M
195.09M
Total operating expenses
153.80M
167.76M
197.42M
197.64M
Operating income
3.42M
26.68M
10.22M
4.49M
Other non operating income
-
-
-
-
EBT including unusual items
9.62M
31.69M
15.24M
9.91M
EBT excluding unusual items
9.62M
31.69M
15.24M
9.91M
Income tax expense
-10.93M
-3.46M
-4.42M
-14.38M
Effective tax rate
-113.63%
-10.91%
-29.03%
-145.09%
Other operating expenses
-
-
-
-
Net income
20.55M
35.15M
19.67M
24.29M
Net profit margin
13.07%
18.08%
9.47%
12.02%
Earnings per share
0.17
0.29
0.16
0.20
Interest and investment income
6.20M
5.02M
5.02M
5.42M
Interest expense
-
-
-
-
Net interest expenses
6.20M
5.02M
5.02M
5.42M
Depreciation and amortization charges
-
-
-
-
EBITDA
3.70M
26.96M
10.51M
4.78M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer